NEW YORK (GenomeWeb) – The Scottish molecular diagnostics firm DestiNA Genomics has received €1.2 million ($1.5 million) in equity investments that it will use to commercialize novel tests for cancer and infectious diseases, the economic development agency Scottish Enterprise said this week.

The new funding for the Edinburgh-based company was led by Vitro Group of Spain, the Scottish Investment Bank (part of Scottish Enterprise), Old College Capital, and private investors in the UK, Spain, Belgium, and Saudi Arabia.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.